OraSure Technologies Inc

Find Ratings Reports
OSUR : NASDAQ : Health Care
$17.73 -0.27 | -1.5%
Today's Range: 17.43 - 18.13
Avg. Daily Volume: 890500.0
07/27/17 - 4:00 PM ET

Financial Analysis


ORASURE TECHNOLOGIES INC's gross profit margin for the first quarter of its fiscal year 2017 has decreased when compared to the same period a year ago. The company managed to grow both sales and net income at a faster pace than the average competitor in its industry this quarter as compared to the same quarter a year ago. ORASURE TECHNOLOGIES INC is extremely liquid. Currently, the Quick Ratio is 9.05 which clearly shows the ability to cover any short-term cash needs. OSUR managed to increase the liquidity from the same period a year ago, despite already having very strong liquidity to begin with. This would indicate improved cash flow.

At the same time, stockholders' equity ("net worth") has greatly increased by 28.10% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q1 FY17 Q1 FY16
Net Sales ($mil)32.5529.09
EBITDA ($mil)4.784.05
EBIT ($mil)3.372.7
Net Income ($mil)12.442.45


Balance Sheet Q1 FY17 Q1 FY16
Cash & Equiv. ($mil)141.46102.25
Total Assets ($mil)232.59188.48
Total Debt ($mil)0.00.0
Equity ($mil)208.83163.02


Profitability Q1 FY17 Q1 FY16
Gross Profit Margin66.7374.49
EBITDA Margin14.6813.93
Operating Margin10.369.28
Sales Turnover0.570.65
Return on Assets12.775.57
Return on Equity14.226.44
Debt Q1 FY17 Q1 FY16
Current Ratio9.886.6
Debt/Capital0.00.0
Interest Expense0.00.0
Interest Coverage0.00.0


Share Data Q1 FY17 Q1 FY16
Shares outstanding (mil)57.6655.48
Div / share0.00.0
EPS0.210.04
Book value / share3.622.94
Institutional Own % n/a n/a
Avg Daily Volume875159.0976474.0

Valuation


BUY. The current P/E ratio indicates a significant discount compared to an average of 47.54 for the Health Care Equipment & Supplies industry and a significant premium compared to the S&P 500 average of 24.66. For additional comparison, its price-to-book ratio of 5.07 indicates a significant premium versus the S&P 500 average of 3.07 and a discount versus the industry average of 5.47. The price-to-sales ratio is well above both the S&P 500 average and the industry average, indicating a premium. Upon assessment of these and other key valuation criteria, ORASURE TECHNOLOGIES INC proves to trade at a discount to investment alternatives within the industry.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
OSUR 35.31 Peers 47.54   OSUR 34.01 Peers 29.38

Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.

OSUR is trading at a significant discount to its peers.

 

Premium. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

OSUR is trading at a premium to its peers.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
OSUR 57.38 Peers 25.74   OSUR 1.37 Peers 0.99

Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations.

OSUR is trading at a significant premium to its peers.

 

Premium. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

OSUR trades at a significant premium to its peers.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
OSUR 5.07 Peers 5.47   OSUR 188.88 Peers 113.75

Average. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

OSUR is trading at a valuation on par with its peers.

 

Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

OSUR is expected to have an earnings growth rate that significantly exceeds its peers.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
OSUR 8.04 Peers 5.22   OSUR 8.16 Peers 14.04

Premium. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

OSUR is trading at a significant premium to its industry.

 

Lower. A sales growth rate that trails the industry implies that a company is losing market share.

OSUR significantly trails its peers on the basis of sales growth

 

 

Latest Stock Upgrades/Downgrades